Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9324 |
High Similarity |
NPD1934 |
Approved |
0.9291 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9291 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9225 |
High Similarity |
NPD1549 |
Phase 2 |
0.9178 |
High Similarity |
NPD1512 |
Approved |
0.9133 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9097 |
High Similarity |
NPD6166 |
Phase 2 |
0.9097 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9097 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.906 |
High Similarity |
NPD4380 |
Phase 2 |
0.9041 |
High Similarity |
NPD1511 |
Approved |
0.898 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8954 |
High Similarity |
NPD7075 |
Discontinued |
0.8954 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8882 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8881 |
High Similarity |
NPD1510 |
Phase 2 |
0.8766 |
High Similarity |
NPD3882 |
Suspended |
0.8758 |
High Similarity |
NPD2801 |
Approved |
0.8701 |
High Similarity |
NPD3817 |
Phase 2 |
0.8696 |
High Similarity |
NPD6797 |
Phase 2 |
0.8693 |
High Similarity |
NPD6801 |
Discontinued |
0.8688 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8658 |
High Similarity |
NPD6799 |
Approved |
0.8642 |
High Similarity |
NPD7251 |
Discontinued |
0.8634 |
High Similarity |
NPD7074 |
Phase 3 |
0.8625 |
High Similarity |
NPD3818 |
Discontinued |
0.8601 |
High Similarity |
NPD1240 |
Approved |
0.8589 |
High Similarity |
NPD7808 |
Phase 3 |
0.8589 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8581 |
High Similarity |
NPD5402 |
Approved |
0.8571 |
High Similarity |
NPD7054 |
Approved |
0.8562 |
High Similarity |
NPD2796 |
Approved |
0.8526 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8519 |
High Similarity |
NPD7472 |
Approved |
0.8487 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8483 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8477 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8462 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8442 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8397 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8354 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8345 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8345 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8303 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8269 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.825 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8235 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.82 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8095 |
Intermediate Similarity |
NPD943 |
Approved |
0.8092 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8069 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.805 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8012 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7974 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7963 |
Intermediate Similarity |
NPD919 |
Approved |
0.7958 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7927 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7908 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7892 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.784 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7838 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7792 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD920 |
Approved |
0.7771 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7771 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7771 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7763 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7712 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7712 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7682 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7677 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7676 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7662 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7658 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7647 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7598 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.758 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7578 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7572 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7572 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7566 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7548 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1653 |
Approved |
0.75 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7486 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7473 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7434 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7415 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7405 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7375 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7347 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7345 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7294 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7294 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7289 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7288 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7283 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7258 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7258 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7258 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7255 |
Intermediate Similarity |
NPD411 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3268 |
Approved |
0.725 |
Intermediate Similarity |
NPD2354 |
Approved |
0.723 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7229 |
Intermediate Similarity |
NPD37 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7211 |
Intermediate Similarity |
NPD17 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7202 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7202 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7202 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7198 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7198 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7196 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD9545 |
Approved |
0.719 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7167 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7158 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7125 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD2654 |
Approved |
0.712 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD7874 |
Approved |
0.711
|
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |